Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron D Bossler

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Cancer|April 25, 2023
RNA sequencing steps toward the first lineTheresa A Boyle, Aaron D Bossler
Cold Spring Harbor Molecular Case Studies|April 24, 2019
Urothelial carcinoma with an <i>NRF1-BRAF</i> rearrangement and response to targeted therapyAlexandra L Isaacson, Natalya V Guseva, Aaron D Bossler, et al.
Human Mutation|June 6, 2006
Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotypeAaron D Bossler, Jennifer Richards, Cicily George, et al.
Journal of Oncology|August 21, 2019
Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse EventsUmang Swami, Varun Monga, Aaron D Bossler, et al.
Neurology|January 14, 2021
CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective AnalysisAutumn Rieken, Aaron D Bossler, Katherine D Mathews, et al.
Familial Cancer|March 28, 2015
Germline mutations predisposing to non-small cell lung cancerGerald H Clamon, Aaron D Bossler, Taher Abu Hejleh, et al.
Melanoma Research|August 8, 2018
Toxicities with targeted therapies after immunotherapy in metastatic melanomaNicole Grogan, Umang Swami, Aaron D Bossler, et al.
Cancer Genetics|April 19, 2018
Biallelic TP53 gain of function mutations in rapidly progressing solid tumorsChristopher M Sande, Brian Chang, Varun Monga, et al.
Cold Spring Harbor Molecular Case Studies|April 3, 2019
<i>BCR-NTRK2</i> fusion in a low-grade glioma with distinctive morphology and unexpected aggressive behaviorKarra A Jones, Aaron D Bossler, Andrew M Bellizzi, et al.
Frontiers in Oncology|June 7, 2023
Ramakrishna R Sompallae, Bilge Dundar, Natalya V Guseva, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Cancer|April 25, 2023
RNA sequencing steps toward the first lineTheresa A Boyle, Aaron D Bossler
Cold Spring Harbor Molecular Case Studies|April 24, 2019
Urothelial carcinoma with an <i>NRF1-BRAF</i> rearrangement and response to targeted therapyAlexandra L Isaacson, Natalya V Guseva, Aaron D Bossler, et al.
Human Mutation|June 6, 2006
Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotypeAaron D Bossler, Jennifer Richards, Cicily George, et al.
Journal of Oncology|August 21, 2019
Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse EventsUmang Swami, Varun Monga, Aaron D Bossler, et al.
Neurology|January 14, 2021
CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective AnalysisAutumn Rieken, Aaron D Bossler, Katherine D Mathews, et al.
Familial Cancer|March 28, 2015
Germline mutations predisposing to non-small cell lung cancerGerald H Clamon, Aaron D Bossler, Taher Abu Hejleh, et al.
Melanoma Research|August 8, 2018
Toxicities with targeted therapies after immunotherapy in metastatic melanomaNicole Grogan, Umang Swami, Aaron D Bossler, et al.
Cancer Genetics|April 19, 2018
Biallelic TP53 gain of function mutations in rapidly progressing solid tumorsChristopher M Sande, Brian Chang, Varun Monga, et al.
Cold Spring Harbor Molecular Case Studies|April 3, 2019
<i>BCR-NTRK2</i> fusion in a low-grade glioma with distinctive morphology and unexpected aggressive behaviorKarra A Jones, Aaron D Bossler, Andrew M Bellizzi, et al.
Frontiers in Oncology|June 7, 2023
Ramakrishna R Sompallae, Bilge Dundar, Natalya V Guseva, et al.
Pageof 4